CLINICAL MANIFESTATIONS AND LABORATORY FINDINGS OF CONGENITAL CYTOMEGALOVIRUS INFECTION IN NEONATOLOGY CENTER OF VIETNAM NATIONAL CHILDREN’S HOSPITAL

Nguyễn Thị Quỳnh Nga, Cao Thị Mai Lê

##plugins.themes.vojs.article.main##

Abstract

Objectives: To document the clinical manifestations and laboratory findingsof congenital cytomegalovirus infection in the Neonatology Center of National Children’s Hospital. Method: Research on 30 newborns were diagnosed with congenital CMV infection admitted to the Neonatal Center, National Children’s Hospital from January 2018 to April 2021. Children are evaluated clinically and subclinically for diseases in the neonatal period. Results: Children with congenital CMV infection have the following characteristics: 50.0% of premature; average birth weight was 2270±540gr; 63.3% SGA. Common clinical symptoms at presentation were jaundice, hepatomegaly, and splenomegaly seen in 43.3% of children. Thrombocytopenia, increased direct bilirubin and increased transaminases were present in 63.3%; 56.7%; 52.4% respectively. 18/28 (64.3%) children with congenital CMV infection had at least one neuroimaging abnormality. 8/15 (53.3%) children had hearing loss or impairment at the first AABR screening and 14.3% had eye abnormalities. The rate of positive CMV-IgM was 88.5%. Conclusions: Congenital CMV infection remains a disease that impactspreterm birth, low birth weight and other severe sequelae. Clinical manifestations are diverse and often involve systemic effects on multiple organs.

##plugins.themes.vojs.article.details##

References

1. Conboy T.J., Pass R.F., Stagno S., et al. Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 1987, 111(3), 343-348.
2. Manicklal S., Emery V.C., Lazzarotto T., et al. The “Silent” Global Burden of Congenital Cytomegalovirus. Clin Microbiol Rev. 2013, 26(1),
86-102.
3. Dollard S.C., Grosse S.D., and Ross D.S. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with
congenital cytomegalovirus infection. Rev Med Virol. 2007,17(5), 355-363.
4. Boppana S.B., Pass R.F., Britt W.J., et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992, 11(2), 93-99.
5. Kylat R.I., Kelly E.N., and Ford-Jones E.L. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus
(SCCMV) infection. Eur J Pediatr. 2006, 165(11), 773-778.
6. Boppana S.B., Ross S.A., and Fowler K.B. Congenital Cytomegalovirus Infection: Clinical Outcome. Clin Infect Dis Off Publ Infect Dis Soc
Am. 2013, 57(Suppl 4), S178-S181.
7. Dreher A.M., Arora N., Fowler K.B., et al. Spectrum of Disease and Outcome in Children with Symptomatic Congenital Cytomegalovirus
Infection. J Pediatr. 2014,164(4), 855-859.
8. Ouellette C.P., Sánchez P.J., Xu Z., et al. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020,11.
9. Lanari M. Neonatal Cytomegalovirus Blood Load and Risk of Sequelae in Symptomatic and Asymptomatic Congenitally Infected Newborns.
Pediatrics. 2006,117(1), e76-e83.
10. Ohyama S., Fujioka K., Fukushima S., et al. Diagnostic Value of Cytomegalovirus IgM Antibodies at Birth in PCR-Confirmed Congenital
Cytomegalovirus Infection. Int J Mol Sci. 2019,20(13), 3239.